Literature DB >> 24819445

Silybin exerts antioxidant effects and induces mitochondrial biogenesis in liver of rat with secondary biliary cirrhosis.

Gaetano Serviddio1, Francesco Bellanti1, Eleonora Stanca2, Paola Lunetti2, Maria Blonda1, Rosanna Tamborra1, Luisa Siculella2, Gianluigi Vendemiale1, Loredana Capobianco3, Anna Maria Giudetti4.   

Abstract

The accumulation of toxic hydrophobic bile acids in hepatocytes, observed during chronic cholestasis, induces substantial modification in the redox state and in mitochondrial functions. Recent reports have suggested a significant role of impaired lipid metabolism in the progression of chronic cholestasis. In this work we report that changes observed in the expression of the lipogenic enzymes acetyl-CoA carboxylase and fatty acid synthase were associated with a decrease in the activity of citrate carrier (CIC), a protein of the inner mitochondrial membrane closely related to hepatic lipogenesis. We also verified that the impairment of citrate transport was dependent on modification of the phospholipid composition of the mitochondrial membrane and on cardiolipin oxidation. Silybin, an extract of silymarin with antioxidant and anti-inflammatory properties, prevented mitochondrial reactive oxygen species (ROS) production, cardiolipin oxidation, and CIC failure in cirrhotic livers but did not affect the expression of lipogenic enzymes. Moreover, supplementation of silybin was also associated with mitochondrial biogenesis. In conclusion, we demonstrate that chronic cholestasis induces cardiolipin oxidation that in turn impairs mitochondrial function and further promotes ROS production. The capacity of silybin to limit mitochondrial failure is part of its hepatoprotective property.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Citrate carrier; Free radicals; Lipogenic enzymes; Mitochondrial biogenesis; Peroxisome proliferator-activated receptor coactivator-1α; Secondary biliary cirrhosis

Mesh:

Substances:

Year:  2014        PMID: 24819445     DOI: 10.1016/j.freeradbiomed.2014.05.002

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  25 in total

Review 1.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

2.  Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism.

Authors:  Caio Mateus Silva; Gustavo Duarte Ferrari; Luciane Carla Alberici; Osmar Malaspina; Karen C M Moraes
Journal:  Mol Cell Biochem       Date:  2020-03-17       Impact factor: 3.396

3.  Curcumin enhances liver SIRT3 expression in the rat model of cirrhosis.

Authors:  Sara Chenari; Fatemeh Safari; Ali Moradi
Journal:  Iran J Basic Med Sci       Date:  2017-12       Impact factor: 2.699

Review 4.  The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells.

Authors:  Parth Trivedi; Shuang Wang; Scott L Friedman
Journal:  Cell Metab       Date:  2020-11-23       Impact factor: 27.287

5.  A lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosis.

Authors:  Daniele Vergara; Michele D'Alessandro; Antonia Rizzello; Lidia De Riccardis; Paola Lunetti; Piero Del Boccio; Francesca De Robertis; Giorgio Trianni; Michele Maffia; Anna M Giudetti
Journal:  BMC Neurosci       Date:  2015-07-24       Impact factor: 3.288

Review 6.  Role of NADPH oxidases in the redox biology of liver fibrosis.

Authors:  Eva Crosas-Molist; Isabel Fabregat
Journal:  Redox Biol       Date:  2015-07-14       Impact factor: 11.799

Review 7.  Nutritional and Hormonal Regulation of Citrate and Carnitine/Acylcarnitine Transporters: Two Mitochondrial Carriers Involved in Fatty Acid Metabolism.

Authors:  Anna M Giudetti; Eleonora Stanca; Luisa Siculella; Gabriele V Gnoni; Fabrizio Damiano
Journal:  Int J Mol Sci       Date:  2016-05-25       Impact factor: 5.923

Review 8.  The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts.

Authors:  Shuang Liang; Tatiana Kisseleva; David A Brenner
Journal:  Front Physiol       Date:  2016-02-02       Impact factor: 4.566

Review 9.  The Role of Oxidative Stress and Antioxidants in Liver Diseases.

Authors:  Sha Li; Hor-Yue Tan; Ning Wang; Zhang-Jin Zhang; Lixing Lao; Chi-Woon Wong; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-11-02       Impact factor: 5.923

Review 10.  Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.

Authors:  Ming Hong; Sha Li; Hor Yue Tan; Ning Wang; Sai-Wah Tsao; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.